California Governor Signs Bill Requiring Greater Drug Price Transparency

Henrietta Strickland
October 12, 2017

The laws cover a variety of programs encouraging the use of vehicles that don't produce greenhouse gases, promoted as necessary elements in helping the state hit its ambitious pollution reduction targets in the coming years.

Pharmaceutical companies in California will soon give notice if they raise prices.

Insurance companies will be required to explain the relationship between drug prices and health care premiums.

Governor Jerry Brown signed the SB 17 law on Monday.

Critics claim the law lacks the ability to enforce prices. The legislation will likely bring a legal challenge to the regulation before it goes into effect in 2019.

"The essence of this bill is pretty simple", Brown said at a Capitol signing ceremony. "This measure is a step at building transparency, truth, exposure to a very important part of our lives". Andres added, "By ignoring the realities of biopharmaceutical development, [the new law] will delay or prevent future biopharmaceutical innovation by driving investment toward other industry sectors that are not burdened with this type of misguided government intrusion".

Jacob Maslow The owner and editor of Legal Scoops, Jacob Maslow, has founded several online newspapers including Daily Forex Report and Conservative Free Press.

Other reports by Click Lancashire

Discuss This Article